Maroon Venture Fund I LP
Advancing Healthy Aging & Longevity
by accelerating innovation and reversing material funding gaps in chronic Population Health conditions & direct Climate Impact on Health
Maroon Venture Fund I LP is a highly differentiated US Venture Capital Fund investing anchor capital in innovative early-stage ventures (Seed to Series B+) to advance Healthy Aging & Longevity by closing material innovation and funding gaps in proactive/personalised, Preventative Healthcare for the early diagnosis and reduction in chronic Population Health conditions, as well as, direct Climate Impact on Health.
Only 9% of Healthcare investment is invested in Preventative & Public Health, despite the fact that the US ranks 60th globally in life expectancy and also represents 64% of global pharma profits. Chronic Population Health conditions impact 50% of the US population and drive 80% of healthcare costs.
Only 2% of Climate finance is invested in Climate-Health related areas, and although the Built Environment represents 50% of our global carbon footprint it is only 4% of Climate investment.
Only 9% of Healthcare investment is invested in Preventative & Public Health, despite the fact that the US ranks 60th globally in life expectancy and also represents 64% of global pharma profits. Chronic Population Health conditions impact 50% of the US population and drive 80% of healthcare costs.
Only 2% of Climate finance is invested in Climate-Health related areas, and although the Built Environment represents 50% of our global carbon footprint it is only 4% of Climate investment.
Advancing Healthy Aging &Longevity
through priority on personalised Preventative Health measures
Climate Impact on Health
through authentic, measurable innovation in the Built Environment, Blue Economy, and AI-driven Climate solutions
Deep Fundamentals Diligence Leadership
complements extensive portfolio credit/risk expertise and portfolio construction providing greater risk mitigation and downside protection for LPs
Strong Investment Track Record
Team collectively has an impressive track record in early-stage venture scaling, investments, IPOs, and successful exits across Health and Climate ventures